Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Blood Transfusion and Agglutination

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...

Blood Transfusion

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

Blood Typing

Blood Typing

Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...

Kidney Transplant I: Introduction

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

While donating blood, one also gives iron: a gift with consequences.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026

Same author

Platelet Additive Solutions and Pathogen Reduction Impact on Transfusion Safety, Patient Management and Platelet Supply.

Transfusion medicine reviews·2025

Same author

New atypical epidemiological profile of parvovirus B19 revealed by molecular screening of blood donations, France, winter 2023/24.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2024

Same author

Hypersensitivity transfusion reactions to fresh frozen plasma: a retrospective analysis of the French hemovigilance network.

Transfusion medicine reviews·2022

Same author

Low rate of RNAemia in blood donations collected during the first wave of COVID-19 in France.

Transfusion·2022

Same author

Correction: An essential role for α4A-tubulin in platelet biogenesis.

Life science alliance·2021

Search research articles

Related Experiment Video

Updated: Jul 14, 2026

Remote Neuronal Activation Coupled with Automated Blood Sampling to Induce and Measure Circulating Luteinizing Hormone in Mice

Remote Neuronal Activation Coupled with Automated Blood Sampling to Induce and Measure Circulating Luteinizing Hormone in Mice

Published on: August 25, 2023

[Future technological evolutions in blood donation qualification].

Azzedine Assal¹, Jean-Yves Py, Cécile Corbi

¹EFS Centre-Atlantique, 2 boulevard Tonnele, 37002 Tours, France. azzedine.assal@efs.sante.fr

Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine

|May 29, 2007

Summary

Future blood screening technologies, including nanobiotechnology, offer limited additional safety benefits over current nucleic acid testing (NAT). While automation advances, cost-effectiveness remains a concern for new screening methods.

More Related Videos

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

Related Experiment Videos

Last Updated: Jul 14, 2026

Remote Neuronal Activation Coupled with Automated Blood Sampling to Induce and Measure Circulating Luteinizing Hormone in Mice

Remote Neuronal Activation Coupled with Automated Blood Sampling to Induce and Measure Circulating Luteinizing Hormone in Mice

Published on: August 25, 2023

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

Area of Science:

Biotechnology
Medical Diagnostics
Nanotechnology

Background:

Blood donation screening has significantly improved blood safety over decades.
Advances in serological and nucleic acid testing (NAT) assays, alongside automated systems, have been key.
The future of NAT development is rapid, with ongoing discussions about new assays and automation.

Purpose of the Study:

To review potential future evolutions in blood screening technologies.
To explore the role of nanobiotechnologies in blood qualification platforms.
To assess the expected benefits and cost-effectiveness of emerging screening technologies.

Main Methods:

Review of current and emerging blood screening technologies.
Analysis of advancements in automated systems and laboratory procedures.
Exploration of nanobiotechnology applications in diagnostics.

Main Results:

Limited added benefit to blood safety is expected from further NAT developments.
Cost-effectiveness of new NAT assays and automation appears poor.
Nanobiotechnologies like DNA microarrays, Lab-On-Chips, biosensors, and nanoparticles are poised to impact screening.

Conclusions:

Future blood screening will likely incorporate nanobiotechnologies.
Robotic pre- and post-analytical procedures represent the next step in laboratory automation.
While advancements continue, the marginal benefit to blood safety from new screening technologies needs careful consideration regarding cost.